Analystreport

PTC Therapeutics (NASDAQ:PTCT) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com